Start Over

Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women

Authors :: Denise R. Nebgen
Susan M. Domchek
Joanne Kotsopoulos
Joanne A. de Hullu
Emma J. Crosbie
Vincent Singh Paramanandam
Monique M.A. Brood ‐ van Zanten
Barbara M. Norquist
Theresa Guise
Serge Rozenberg
Allison W. Kurian
Holly J. Pederson
Nese Yuksel
Rachel Michaelson‐Cohen
Sharon L. Bober
Agnaldo Lopes da Silva Filho
Nora Johansen
F. Guidozzi
D. Gareth Evans
Usha Menon
Sheryl A. Kingsberg
C. Bethan Powell
Giovanni Grandi
Claudia Marchetti
Michelle Jacobson
Donal J. Brennan
Martha Hickey
Source :: Nebgen, D R, Domchek, S M, Kotsopoulos, J, de Hullu, J A, Crosbie, E J, Paramanandam, V S, van Zanten, M B, Norquist, B M, Guise, T, Rozenberg, S, Kurian, A W, Pederson, H J, Yuksel, N, Michaelson-Cohen, R, Bober, S L, da Silva Filho, A L, Johansen, N, Guidozzi, F, Evans, D G, Menon, U, Kingsberg, S A, Powell, C B, Grandi, G, Marchetti, C, Jacobson, M, Brennan, D J & Hickey, M 2023, ' Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women : Scoping review and international consensus recommendations ', BJOG: An International Journal of Obstetrics & Gynaecology . https://doi.org/10.1111/1471-0528.17511
Publication Year :: 2023
Abstract: Women at high inherited risk of ovarian cancer are offered risk-reducing salpingo-oophorectomy (RRSO) from age 35 to 45 years. Although potentially life-saving, RRSO may induce symptoms that negatively affect quality of life and impair long-term health. Clinical care following RRSO is often suboptimal. This scoping review describes how RRSO affects short- and long-term health and provides evidence-based international consensus recommendations for care from preoperative counselling to long-term disease prevention. This includes the efficacy and safety of hormonal and non-hormonal treatments for vasomotor symptoms, sleep disturbance and sexual dysfunction and effective approaches to prevent bone and cardiovascular disease.